Think Research Corporation Closes Acquisition of Bio Pharma Services Inc.
September 13, 2021
Toronto, ON, September 13, 2021 – Think Research Corporation (TSXV:THNK) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, today announced that it has closed its previously announced acquisition of all of the issued and outstanding shares of BioPharma, a leading contract research organization to pharmaceutical companies globally, from its securityholders (the “BioPharma Securityholders”). Think CEO Sachin Aggarwal said, “We extend a warm welcome from the Think family to the talented BioPharma team. The closing of this acquisition offers not just immediate financial value to our shareholders, but it also represents a key pillar in our knowledge lifecycle, allowing us to utilize systems and solutions that support the clinical decision-making process, standardize care, and, ultimately, improve patient outcomes. We look forward to supporting BioPharma in its digital transformation to create synergies in the near term.” Visit the Think Research website to view the full release.
Think Research Finds Mental Health Is the Top Issue Healthcare Providers Want to Educate Themselves On
September 9, 2021
TORONTO, ON, September 9, 2021 – Think Research Corporation, a company focused on transforming healthcare through digital health software solutions, today announced survey results showing six in 10 Canadian clinicians say mental health is the top healthcare issue they want to further educate themselves on. The survey, led by MDBriefCase, the leading provider of continuing medical education and a member of the Think family of companies, found that nearly 62 per cent of healthcare providers ranked mental health is the most valuable therapeutic area of continuing education for them, signalling the importance of supporting patients’ ongoing well-being coming out of the COVID-19 crisis. Research shows that mental health has declined across age groups during the pandemic, including children and adolescents, adults, frontline workers and seniors. Early mental health intervention and treatment is shown to improve outcomes and reduce healthcare spending. Think’s Senior Medical Advisor Dr. Naila Kassam said “Almost half of all Canadians say their mental health has worsened since the start of the pandemic. The fact that clinicians report a strong desire to learn more about mental health and continue their education shows how seriously they are taking it as a core part of someone’s overall well-being. “As best […]
Think Research Completes Acquisition of MDBriefCase, an International Provider of Accredited Digital Education to Clinicians
January 29, 2021
Original press release posted on CNW.Jan 29, 2021, 13:00 ET Strategic acquisition positions Think Research to educate clinicians internationally on the latest evidence and protocols and also to provide them with the digital tools required to immediately deploy that knowledge into their practice, thereby improving patient care, safety and outcomes Combined, Think Research and MDBriefCase reach a network of nearly 300,000 global healthcare professionals in Canada, Europe, Australia, Africa and the Middle East With the acquisition of MDBriefCase, trailing pro forma revenue grows to more than $36M TORONTO, Jan. 29, 2021 /CNW/ – Think Research Corporation (TSXV: THNK) or (the “Company” or “Think Research“), a company focused on transforming healthcare through integrated digital health solutions, today announced that it has completed the previously announced definitive agreement to acquire all of the issued and outstanding shares of MDBriefCase Group Inc. (“MDBriefCase“), a leading provider of online continuing medical education (“CME“) and professional development solutions for clinicians and a portfolio company of Persistence Capital Partners. The acquisition was made for an aggregate purchase price of $25.3M in Think Research shares and cash, and a total enterprise value of $28.5M. Sachin Aggarwal, CEO of Think Research, said, “This is a highly strategic acquisition for Think Research and we are eager to get going on integrating MDBriefCase […]
Think Research Corp. acquires MDBriefCase Group Inc.
January 19, 2021
TORONTO, Jan. 18, 2021 – Think Research Corporation, a company focused on transforming healthcare through integrated digital health solutions, today announced that it has entered into a share purchase agreement to acquire all of the issued and outstanding shares of MDBriefCase Group Inc. (“MDBriefCase”), a leading provider of online continuing medical education (CME) and professional development solutions for clinicians and a portfolio company of Persistence Capital Partners. Through this transaction (the “Transaction”), Think Research will be uniquely positioned to educate clinicians internationally on the latest evidence and protocols and also to provide them with the digital tools required to immediately deploy that knowledge into their practice, thereby improving patient care, safety and outcomes. The combination of Think Research and MDBriefCase is expected to create a valuable data feedback loop where data collected through frontline clinical tools can monitor how a clinician’s practice has changed as a result of CME and other programs, and whether adjustments need to be made to further improve CME courses or clinical decision support tools. The Transaction builds on the Company’s momentum and scale following the commencement of its listing on the TSX Venture Exchange (the “TSXV”) on December 30, 2020 and the announcement on January […]
MDBriefCase and IQVIA collaborate to provide access to specialized e-learning and engagement for HCPs in the Middle East, Africa and South Asia
January 4, 2021
4th January 2021: MDBriefcase Group Inc. (MDBC), Canada’s leading provider of online continuing medical education and professional development for healthcare providers, is excited to announce a strategic alliance with IQVIA in the Middle East, Africa and South Asia. IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. Through this alliance, HCPs can access on-demand medical e-learning solutions and engagement services by MDBC on IQVIAs HCP Space™, a holistic networking and learning platform for healthcare professionals. With over 54,000 registered users it is one of the fastest growing platforms in the region. Professionals on HCP Space will gain access to MDBCs latest content, digital networks, and learning resources available. “We are thrilled to have the opportunity to partner with IQVIA to build upon a collective vision we share to connect and support the healthcare community. We now offer a wider and more impactful range of education and communication initiatives,” said Janet Kimura, SVP of MDBC. “This collaboration reflects our ongoing commitment to growth and enabling the healthcare community to quickly and practically integrate evidence, medical insights and knowledge from a preeminent platform that will improve the lives of the patients.” […]
Our partnership with COSA
October 29, 2020
Our partnership with COSA accommodates your eLearning CPD needs. Explore our three most recent CPD programs (listed below) which are developed in collaboration with or endorsed by the Clinical Oncology Society of Australia (COSA) and delivered to you by leading Australian professors and oncology consultants. Note: Fellows of the Royal Australasian College of Physicians (RACP) can easily claim their CPD credits in MyCPD.
MDBriefCase Acquires OncologyEducation to Significantly Advance its Oncology Platform
October 1, 2020
MDBriefCase Group Inc. (MDBC), Canada’s leading provider of online continuing medical education and professional development for healthcare providers, is excited to announce the acquisition of OncologyEducation. OncologyEducation is a comprehensive online platform providing evidence-based oncology content, developed and authored by a leading, international faculty of oncology professionals. “We are excited to add OncologyEducation to our family of online educational resources for healthcare professionals,” said Jason Flowerday, CEO of MDBC. “This acquisition aligns with our commitment to investing in critical therapeutic areas to provide our worldwide members with the latest scientific resources for informed healthcare decision-making. Together, MDBriefCase and OncologyEducation serves to provide the pharmaceutical and biotech sectors with improved access and reach to innovative medical education opportunities and programming.” “OncologyEducation was founded on the principle of improving patient care by providing oncology professionals worldwide with the latest oncology information resources,” said Dr. Berry, co-founder of OncologyEducation. “We are a global organization that has grown to have strong credibility among healthcare professionals around the world, and we are confident that MDBriefCase’s track record of global success can further expand the reach and impact of quality oncology education through its innovative offerings.” Since 2001, MDBC has delivered interactive, peer-reviewed, and evidence-based programs […]
MDBriefCase Group Announces New Expert Advisors and Transforms its Online Learning Platform
September 18, 2019
TORONTO, Sept. 18, 2019 (GLOBE NEWSWIRE) — MDBriefCase Group Inc. (“MDBC” or the “Company”), a global leader in e-learning products and services that aims to accelerate better decision-making in healthcare, announced collaborations with two expert advisors, Dr. David Strain, Senior Clinical Lecturer at the University of Exeter (London, UK), and Dr. Mohamed Farghaly, Associate Professor at Dubai Medical College (Dubai, UAE). These collaborations will continue to support MDBC’s foothold as one of the foremost online, continuing professional development providers across Canada, Australia, the United Kingdom, Europe and the Middle East. These exciting new collaborations come at a transformational time in the Company’s history as a global leader in online medical education, as they coincide with the launch of MDBC’s enhanced digital presence including a new learning platform that applies cutting-edge instructional design to all of MDBC’s global products and services. “The opportunity to work with Drs. Strain and Farghaly as expert advisors to the Company provides MDBriefCase with access to highly-respected thought leaders with deep clinical and industry insights,” says Jason Flowerday, CEO of MDBC. “Our entry, and the acceleration of MDBC’s world-class online medical education, into the UK, Europe and the Middle East is an organizational priority that will […]